Athira Pharma, Inc.
NASDAQ:ATHA
0.542 (USD) • At close December 24, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 0 | 0 | 1.656 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 0 | 0.242 | 0.242 | 0.245 | 0.244 | 0.297 | 0.287 | 0.288 | 0.293 | 0.268 | 0.199 | 0.126 | 0.123 | 0.118 | 0.112 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinst
| 0 | -0.242 | -0.242 | 1.411 | -0.244 | -0.297 | -0.287 | -0.288 | -0.293 | -0.268 | -0.199 | -0.126 | -0.123 | -0.118 | -0.112 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinstmarge
| 0 | 0 | 0 | 0.852 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 17.922 | 21.912 | 20.994 | 23.435 | 27.202 | 21.615 | 21.293 | 15.236 | 16.965 | 14.803 | 14.46 | 12.618 | 10.707 | 12.024 | 7.445 | 5.187 | 5.83 | 1.677 | 0.592 | 0.658 | 1.026 | 1.055 | 1.055 |
| Algemene en administratieve kosten
| 7.572 | 5.874 | 6.451 | 6.962 | 7.84 | 10.025 | 8.477 | 7.691 | 7.168 | 8.766 | 8.927 | 6.16 | 7.119 | 4.613 | 3.336 | 3.892 | 1.567 | 0.575 | 0.675 | 0.459 | 0.509 | 0.344 | 0.344 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 7.572 | 5.874 | 6.451 | 6.962 | 7.84 | 10.025 | 8.477 | 7.691 | 7.168 | 8.766 | 8.927 | 6.16 | 7.119 | 4.613 | 3.336 | 3.892 | 1.567 | 0.575 | 0.675 | 0.459 | 0.509 | 0.344 | 0.344 |
| Overige kosten
| 4.127 | 1.169 | 1.35 | 1.729 | 2.072 | 2.043 | -0.157 | -1.227 | -2.959 | 0.493 | -2.234 | 6.499 | -2.079 | -2.589 | -1.831 | -0.817 | -1.059 | -0.108 | 0.097 | -0.049 | -0.021 | 0 | 0 |
| Bedrijfskosten
| 29.621 | 27.786 | 27.445 | 30.397 | 35.042 | 31.64 | 29.613 | 21.7 | 21.174 | 24.828 | 21.153 | 16.442 | 15.747 | 14.048 | 8.95 | 7.78 | 7.397 | 2.252 | 1.245 | 0.835 | 1.346 | 1.276 | 1.276 |
| Bedrijfsresultaat
| -29.621 | -28.028 | -27.687 | -30.642 | -35.042 | -31.64 | -29.77 | -32.927 | -24.133 | -23.569 | -23.387 | -18.778 | -17.826 | -16.637 | -10.781 | -9.079 | -7.397 | -2.252 | -1.267 | -1.117 | -1.535 | -1.399 | -1.399 |
| Bedrijfsresultaat ratio
| 0 | 0 | 0 | -18.504 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 0.88 | 1.169 | 1.35 | 1.729 | 2.072 | 2.043 | 1.95 | 2.792 | 3.944 | -0.766 | 2.407 | 2.439 | 2.152 | 2.663 | 1.915 | 1.377 | -1.059 | 0.26 | -0.538 | 0.143 | 0.005 | 0.07 | 0.07 |
| Inkomen voor belasting
| -28.741 | -26.859 | -26.337 | -27.285 | -32.97 | -29.597 | -27.82 | -30.135 | -20.189 | -24.335 | -20.98 | -16.339 | -15.674 | -13.974 | -8.866 | -7.702 | -8.456 | -1.992 | -1.805 | -0.974 | -1.53 | -1.329 | -1.329 |
| Inkomen voor belasting ratio
| 0 | 0 | 0 | -16.476 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0 | 0 | 0.199 | 2.194 | -0.244 | 0.122 | -1.95 | -4.433 | -3.944 | -0.047 | -2.407 | 1.978 | 2.153 | 2.589 | 1.915 | 0.421 | -0.001 | 0.144 | 0.19 | -0.179 | -0.103 | 0.07 | 0.07 |
| Nettowinst
| -28.741 | -26.859 | -26.337 | -27.285 | -32.97 | -29.597 | -25.87 | -25.702 | -16.245 | -24.335 | -18.573 | -16.339 | -15.674 | -13.974 | -8.866 | -7.702 | -8.456 | -1.992 | -1.805 | -0.974 | -1.53 | -1.329 | -1.329 |
| Nettowinstmarge
| 0 | 0 | 0 | -16.476 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -0.75 | -0.7 | -0.69 | -0.72 | -0.87 | -0.78 | -0.68 | -0.68 | -0.43 | -0.65 | -0.49 | -0.44 | -0.42 | -0.38 | -0.25 | -0.22 | -1.12 | -0.069 | -0.21 | -0.11 | -0.18 | -0.37 | -0.37 |
| Verwaterde WPA
| -0.75 | -0.7 | -0.69 | -0.72 | -0.87 | -0.78 | -0.68 | -0.68 | -0.43 | -0.65 | -0.49 | -0.44 | -0.42 | -0.38 | -0.25 | -0.22 | -1.12 | -0.069 | -0.21 | -0.11 | -0.18 | -0.37 | -0.37 |
| EBITDA
| -25.251 | -27.786 | -27.445 | -30.397 | -34.798 | -31.396 | -29.534 | -22.688 | -19.896 | -24.067 | -20.781 | -16.211 | -15.55 | -13.856 | -8.754 | -9.079 | -8.456 | -1.844 | -1.587 | -0.877 | 0 | 0 | 0 |
| EBITDA ratio
| 0 | 0 | 0 | -18.356 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |